GlassScriptPhysician profile
Christina Milo
NPI 1265024731
$1,410.35
in general payments reported to CMS, 2019-2025
18 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.79 · 2022: $241 · 2023: $198 · 2024: $719 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,075.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $295.48 | 2021-2025 | Slynd |
| Medtronic, INC. | $146.06 | 2022-2024 | Interstim |
| Astellas Pharma US INC | $126.61 | 2023-2025 | Veozah |
| Lilly USA, LLC | $124.99 | 2024 | Mounjaro |
| Glaxosmithkline, LLC. | $124.99 | 2024 | Arexvy |
| Organon LLC | $115.16 | 2021-2023 | Nexplanon |
| Biohaven Pharmaceutical Holding Company LTD. | $83.06 | 2022 | |
| Abbvie INC. | $77.82 | 2021-2022 | |
| Hologic Sales and Service, LLC | $75.48 | 2024 | Thinprep 2000 Processor, Aptima |
| Becton, Dickinson and Company | $56.12 | 2021-2024 | Bd Onclarity |
| Pfizer INC. | $47.43 | 2023 | |
| Mayne Pharma Commercial LLC | $27.28 | 2024 | |
| Exact Sciences Corporation | $24.15 | 2025 | The Cologuard Plus Collection Kit |
| Scynexis, INC. | $21.56 | 2022 | |
| Amgen INC. | $18.86 | 2024 | Prolia, Evenity |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $15.42 | 2023 | Myfembree |
| Shield Therapeutics INC | $14.97 | 2024 | |
| Avion Pharmaceuticals | $14.91 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Milo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.